Capital Fund Management S.A. Astrazeneca PLC Put Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $981,376 - $1.12 Million	12,800 New	12,800 $997,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $246,429 - $272,460	-3,800 Reduced 20.0%	15,200 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1.38 Million - $1.5 Million	-19,800 Reduced 51.03%	19,000 $1.36 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $1.18 Million - $1.34 Million	-18,700 Reduced 32.52%	38,800 $2.69 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $303,576 - $394,464	-5,600 Reduced 8.87%	57,500 $3.9 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $302,214 - $773,775	-5,700 Reduced 8.28%	63,100 $3.46 Billion
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $3.73 Million - $4.48 Million	63,000 Added 1086.21%	68,800 $4.55 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $246,268 - $292,668	5,800 New	5,800 $289,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.